CHANELLE ANIMAL HEALTH LIMITED

Company Registration Number:
02598733 (England and Wales)

Unaudited statutory accounts for the year ended 30 April 2024

Period of accounts

Start date: 1 May 2023

End date: 30 April 2024

CHANELLE ANIMAL HEALTH LIMITED

Contents of the Financial Statements

for the Period Ended 30 April 2024

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

CHANELLE ANIMAL HEALTH LIMITED

Directors' report period ended 30 April 2024

The directors present their report with the financial statements of the company for the period ended 30 April 2024

Principal activities of the company

The company’s principal activity during the year was the operation of a wholesale veterinary business.

Political and charitable donations

The company made no political or charitable donations nor incurred any political expenditure during the year.



Directors

The directors shown below have held office during the period of
1 May 2023 to 2 April 2024

Michael H Burke
Ulick Burke
Kelly Burke
Joan Marie Burke


The directors shown below have held office during the period of
2 April 2024 to 30 April 2024

Aubrey Mulveen
Kara Walsh


Secretary Kara Walsh

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
18 November 2024

And signed on behalf of the board by:
Name: Aubrey Mulveen
Status: Director

CHANELLE ANIMAL HEALTH LIMITED

Profit And Loss Account

for the Period Ended 30 April 2024

2024 2023


£

£
Turnover: 6,504,257 4,817,278
Cost of sales: ( 5,407,247 ) ( 3,977,683 )
Gross profit(or loss): 1,097,010 839,595
Administrative expenses: ( 928,003 ) ( 1,003,100 )
Operating profit(or loss): 169,007 (163,505)
Interest receivable and similar income: 0 7,443
Interest payable and similar charges: ( 854 ) 0
Profit(or loss) before tax: 168,153 (156,062)
Tax: ( 41,341 ) 39,798
Profit(or loss) for the financial year: 126,812 (116,264)

CHANELLE ANIMAL HEALTH LIMITED

Balance sheet

As at 30 April 2024

Notes 2024 2023


£

£
Fixed assets
Intangible assets:   0 0
Tangible assets:   0 0
Investments:   0 0
Total fixed assets: 0 0
Current assets
Stocks: 3 1,501,434 2,676,466
Debtors: 4 3,670,404 3,372,021
Cash at bank and in hand: 543,185 356,034
Total current assets: 5,715,023 6,404,521
Creditors: amounts falling due within one year: 5 ( 4,478,363 ) ( 5,294,673 )
Net current assets (liabilities): 1,236,660 1,109,848
Total assets less current liabilities: 1,236,660 1,109,848
Total net assets (liabilities): 1,236,660 1,109,848
Capital and reserves
Called up share capital: 2 2
Profit and loss account: 1,236,658 1,109,846
Total Shareholders' funds: 1,236,660 1,109,848

The notes form part of these financial statements

CHANELLE ANIMAL HEALTH LIMITED

Balance sheet statements

For the year ending 30 April 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 18 November 2024
and signed on behalf of the board by:

Name: Aubrey Mulveen
Status: Director

The notes form part of these financial statements

CHANELLE ANIMAL HEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer, usually on dispatch of the goods, the amount of turnover can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

    Tangible fixed assets depreciation policy

    Tangible fixed assets are stated at cost less accumulated depreciation and accumulated impairment losses. Where parts of an item of tangible fixed assets have different useful lives, they are accounted for as separate items of tangible fixed assets, for example land is treated separately from buildings. The company assesses at each reporting date whether tangible fixed assets are impaired. Depreciation is charged to the profit and loss account on a straight-line basis over the estimated useful lives of each part of an item of tangible fixed assets. The estimated useful lives are as follows Motor vehicles is 20 percent reducing balance Fixtures, fittings and equipment is 12.5 percent straight line Computer equipment is 33.33 percent straight line Depreciation methods, useful lives and residual values are reviewed if there is an indication of a significant change since the last annual reporting date in the pattern by which the company expects to consume an asset’s future economic benefits.

    Other accounting policies

    Interest Interest receivable and interest payable comprises bank interest and represent foreign exchange gains and losses which are reported on a net basis. Inventories Inventories comprise goods held for resale. Inventories are stated at the lower of cost and net realisable value. Cost is calculated on a first in, first out basis and includes invoice price, import duties and transportation costs. Net realisable value comprises the actual or estimated selling price less all further costs to completion or to be incurred in marketing, selling and distribution. At the end of each reporting period inventories are assessed for impairment. If an item of inventory is impaired, the identified inventory is reduced to its selling price less costs to complete and sell and an impairment charge is recognised in the profit and loss account. Where a reversal of the impairment is recognised the impairment charge is reversed, up to the original impairment loss, and is recognised as a credit in the profit and loss account. Trade and other debtors and creditors Trade and other debtors are recognised initially at transaction price plus attributable transaction costs. Trade and other creditors are recognised initially at transaction price less attributable transaction costs. Cash and cash equivalents Cash and cash equivalents comprise cash balances and demand deposits. Taxation Tax is recognised in the profit and loss account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case tax is also recognised in other comprehensive income or directly in equity respectively.

CHANELLE ANIMAL HEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2024

  • 2. Employees

    2024 2023
    Average number of employees during the period 2 4

CHANELLE ANIMAL HEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2024

3. Stocks

2024 2023
£ £
Stocks 1,501,434 2,676,466
Total 1,501,434 2,676,466

CHANELLE ANIMAL HEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2024

4. Debtors

2024 2023
£ £
Trade debtors 1,862,802 1,361,713
Prepayments and accrued income 17,325 8,583
Other debtors 1,790,277 2,001,725
Total 3,670,404 3,372,021

CHANELLE ANIMAL HEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2024

5. Creditors: amounts falling due within one year note

2024 2023
£ £
Trade creditors 188,330 399,112
Taxation and social security 293,126 183,976
Accruals and deferred income 66,142 71,556
Other creditors 3,930,765 4,640,029
Total 4,478,363 5,294,673

CHANELLE ANIMAL HEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2024

6. Financial Commitments

The company had no material capital commitments at the financial year ended 30 April 2024 (2023: £Nil).